longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

PRME

PRME
3.4203.93%( -0.140 )

LongbridgeAI

Prime Medicine shares are trading lower after the company reported worse-than-expected Q1 sales results.

benzinga_article
May 7, 2026 at 04:58 PM
Prime Medicine shares are trading lower after the company reported worse-than-expected Q1 sales results.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Prime Medicine

Prime Medicine

USPRME

-3.79%

Invesco Nasdaq Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

USIBBQ

SPDR S&P Biotech

SPDR S&P Biotech

USXBI